No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ETON Eton Pharmaceutical
- 12.570
- +0.290+2.36%
Close Dec 20 16:00 ET
- 12.570
- 0.0000.00%
Post 20:01 ET
327.47MMarket Cap-59.86P/E (TTM)
13.290High12.170Low281.56KVolume12.290Open12.280Pre Close3.60MTurnover1.37%Turnover RatioLossP/E (Static)26.05MShares13.98052wk High20.51P/B257.75MFloat Cap3.03052wk Low--Dividend TTM20.51MShs Float13.980Historical High--Div YieldTTM9.12%Amplitude1.950Historical Low12.790Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Craig-Hallum Initiates Eton Pharmaceutical(ETON.US) With Buy Rating
Eton Pharmaceuticals Closes Acquisition Of Increlex(R) (Mecasermin Injection) >ETON
Express News | Eton Pharmaceuticals Closes Acquisition of Increlex® (Mecasermin Injection)
Eton Pharmaceuticals Closes Acquisition of Increlex (Mecasermin Injection)
Eton Pharmaceuticals Announced The Full Readout From The Clinical Trial Evaluating PKU GOLIKE As A Protein Substitute For Phenylketonuria In Patients During Prolonged Fasting Periods
Express News | Eton Pharmaceuticals Announces Final Readout of Pku Golike® Clinical Trial
Heat List
US
Overall
Symbol
Price
% Chg
No Data